Videos

Pharmacy Times® interviewed Alex Hontos, JD, partner at Dorsey & Whitney, on the executive order President Biden signed directing agencies to utilize the Defense Production Act, among other tools, to prioritize production of COVID-19 vaccines and material.

Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic his recent CAEL-101 findings, and how it can help shape treatment for patients living with amyloid light chain amyloidosis.

Pharmacy Times® interviewed Sandra Divarco, JD, partner at McDermott Will & Emery, on the complex considerations facing hospitals, health systems, and pharmacies during COVID-19 vaccinations.

Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about what CAEL-101 is, how it works, and how it is used to treat patients with amyloid light chain amyloidosis.

Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about his new research surrounding CAEL-101, a treatment for patients living with amyloid light chain amyloidosis.

Steve Moore, PharmD, chairman of the Pharmacists Society of the State of New York, said the Federal Retail Pharmacy Program will work alongside his state’s own rollouts to get shots in arms.

Pharmacy Times® interviewed Nurisha Wade, MBA, and Farah Towfic, PharmD, MBA, of US Pharmacopeia, on how the release of the COVID-19 Vaccine Handling Toolkit may help pharmacists quickly and safely vaccinate.

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how the COVID-19 pandemic is going to impact cancer mortality.

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how screening can help reduce cancer deaths.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what’s on the horizon of interest for independent pharmacy in 2021.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the steps necessary to support the long-term viability of independent community pharmacies.

Despite rising cancer death rates during the coronavirus disease 2019 (COVID-19) pandemic, Randall A. Oyer, MD, said it's not too late to reverse it.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on solutions that can help support independent community pharmacies now and in the future.

In an interview, Nishita Hira, PharmD, CSP, clinical program manager at AllianceRx Walgreens Prime, discussed the role specialty pharmacists can play during the COVID-19 vaccine rollout.

Pharmacy Times® interviewed Micah Cost, PharmD, MS, who was recently selected as the new chief executive officer of PQA, on his plans for the future of the organization.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what the implementation of the recent unanimous SCOTUS ruling on Rutledge v. PCMA may look like.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what proper screening and protection looks like for health care workers administering the COVID-19 vaccine looks like.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the role of independent pharmacies in the country during the COVID-19 pandemic.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent SCOTUS ruling on Rutledge v. PCMA may help independent community pharmacies rebuild what may have been lost due to low reimbursement rates.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent unanimous SCOTUS ruling on Rutledge v. PCMA will impact independent pharmacies across the country.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how the COVID-19 pandemic has reinforced pharmacists’ purpose of championing the health of every community.

Pharmacy Times® interviewed Thomas D’Angelo, RPh, president of the Pharmacists Society of the State of New York, on how independent pharmacies may be well-positioned to assist in the administration of COVID-19 vaccines.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how the hours of operation of pharmacies involved in the COVID-19 vaccinations have been impacted by vaccination efforts.

Pharmacy Times® interviewed Emily Cook, a partner with McDermott Will & Emery, on the release of the final 340B Administrative Dispute Resolution (ADR) Rule and what it may mean for pharmacies.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how COVID-19 vaccinations has affected the day-to-day of pharmacies.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.

Pharmacy Times® interviewed Chad Landmon, the chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the potential impact President-elect Joseph Biden’s cabinet nominations may have on the pharmacy field in 2021.

Although safety and efficacy have been proven, a few questions still remain about how long the vaccines will be effective and whether they prevent asymptomatic infection.